Detalhe da pesquisa
1.
Bispecific antibodies promote natural killer cell-mediated elimination of HIV-1 reservoir cells.
Nat Immunol
; 25(3): 462-470, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38278966
2.
Allogeneic immunity clears latent virus following allogeneic stem cell transplantation in SIV-infected ART-suppressed macaques.
Immunity
; 56(7): 1649-1663.e5, 2023 07 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37236188
3.
HIV-1 integration landscape during latent and active infection.
Cell
; 160(3): 420-32, 2015 Jan 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-25635456
4.
Replication-competent noninduced proviruses in the latent reservoir increase barrier to HIV-1 cure.
Cell
; 155(3): 540-51, 2013 Oct 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-24243014
5.
Transcriptional Reprogramming during Effector-to-Memory Transition Renders CD4+ T Cells Permissive for Latent HIV-1 Infection.
Immunity
; 47(4): 766-775.e3, 2017 10 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-29045905
6.
Biphasic decay of intact SHIV genomes following initiation of antiretroviral therapy complicates analysis of interventions targeting the reservoir.
Proc Natl Acad Sci U S A
; 120(43): e2313209120, 2023 Oct 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-37844236
7.
A quantitative approach for measuring the reservoir of latent HIV-1 proviruses.
Nature
; 566(7742): 120-125, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30700913
8.
Complex decay dynamics of HIV virions, intact and defective proviruses, and 2LTR circles following initiation of antiretroviral therapy.
Proc Natl Acad Sci U S A
; 119(6)2022 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35110411
9.
TCR-mimic bispecific antibodies to target the HIV-1 reservoir.
Proc Natl Acad Sci U S A
; 119(15): e2123406119, 2022 04 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35394875
10.
Measuring the latent reservoir for HIV-1: Quantification bias in near full-length genome sequencing methods.
PLoS Pathog
; 18(9): e1010845, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36074794
11.
Autologous IgG antibodies block outgrowth of a substantial but variable fraction of viruses in the latent reservoir for HIV-1.
Proc Natl Acad Sci U S A
; 117(50): 32066-32077, 2020 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33239444
12.
HSF1 inhibition attenuates HIV-1 latency reversal mediated by several candidate LRAs In Vitro and Ex Vivo.
Proc Natl Acad Sci U S A
; 117(27): 15763-15771, 2020 07 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32571938
13.
Intact proviral DNA assay analysis of large cohorts of people with HIV provides a benchmark for the frequency and composition of persistent proviral DNA.
Proc Natl Acad Sci U S A
; 117(31): 18692-18700, 2020 08 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32690683
14.
Low Inducibility of Latent Human Immunodeficiency Virus Type 1 Proviruses as a Major Barrier to Cure.
J Infect Dis
; 223(12 Suppl 2): 13-21, 2021 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33586775
15.
Nonstructured Treatment Interruptions Are Associated With Higher Human Immunodeficiency Virus Reservoir Size Measured by Intact Proviral DNA Assay in People Who Inject Drugs.
J Infect Dis
; 223(11): 1905-1913, 2021 06 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33037877
16.
Selective Decay of Intact HIV-1 Proviral DNA on Antiretroviral Therapy.
J Infect Dis
; 223(2): 225-233, 2021 02 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32823274
17.
Assessing the Suitability of Next-Generation Viral Outgrowth Assays to Measure Human Immunodeficiency Virus 1 Latent Reservoir Size.
J Infect Dis
; 224(7): 1209-1218, 2021 10 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-32147687
18.
Similar Frequency and Inducibility of Intact Human Immunodeficiency Virus-1 Proviruses in Blood and Lymph Nodes.
J Infect Dis
; 224(2): 258-268, 2021 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33269401
19.
Impact of Anti-PD-1 and Anti-CTLA-4 on the Human Immunodeficiency Virus (HIV) Reservoir in People Living With HIV With Cancer on Antiretroviral Therapy: The AIDS Malignancy Consortium 095 Study.
Clin Infect Dis
; 73(7): e1973-e1981, 2021 10 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33677480
20.
Broad CTL response is required to clear latent HIV-1 due to dominance of escape mutations.
Nature
; 517(7534): 381-5, 2015 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25561180